JP2018513116A5 - - Google Patents

Download PDF

Info

Publication number
JP2018513116A5
JP2018513116A5 JP2017546603A JP2017546603A JP2018513116A5 JP 2018513116 A5 JP2018513116 A5 JP 2018513116A5 JP 2017546603 A JP2017546603 A JP 2017546603A JP 2017546603 A JP2017546603 A JP 2017546603A JP 2018513116 A5 JP2018513116 A5 JP 2018513116A5
Authority
JP
Japan
Prior art keywords
seq
cdr2
disease
cdr3
cdr1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017546603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018513116A (ja
JP7274259B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/054524 external-priority patent/WO2016139297A1/en
Publication of JP2018513116A publication Critical patent/JP2018513116A/ja
Publication of JP2018513116A5 publication Critical patent/JP2018513116A5/ja
Priority to JP2021112865A priority Critical patent/JP7818795B2/ja
Application granted granted Critical
Publication of JP7274259B2 publication Critical patent/JP7274259B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017546603A 2015-03-05 2016-03-03 炎症性疾患におけるil-18結合タンパク質(il-18bp)および抗体 Active JP7274259B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021112865A JP7818795B2 (ja) 2015-03-05 2021-07-07 炎症性疾患におけるil-18結合タンパク質(il-18bp)および抗体

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP15157742.6 2015-03-05
EP15157742 2015-03-05
EP15158781 2015-03-12
EP15158781.3 2015-03-12
EP15186626 2015-09-24
EP15186626.6 2015-09-24
PCT/EP2016/054524 WO2016139297A1 (en) 2015-03-05 2016-03-03 Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021112865A Division JP7818795B2 (ja) 2015-03-05 2021-07-07 炎症性疾患におけるil-18結合タンパク質(il-18bp)および抗体

Publications (3)

Publication Number Publication Date
JP2018513116A JP2018513116A (ja) 2018-05-24
JP2018513116A5 true JP2018513116A5 (cg-RX-API-DMAC7.html) 2019-04-11
JP7274259B2 JP7274259B2 (ja) 2023-05-16

Family

ID=55453181

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017546603A Active JP7274259B2 (ja) 2015-03-05 2016-03-03 炎症性疾患におけるil-18結合タンパク質(il-18bp)および抗体
JP2021112865A Active JP7818795B2 (ja) 2015-03-05 2021-07-07 炎症性疾患におけるil-18結合タンパク質(il-18bp)および抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021112865A Active JP7818795B2 (ja) 2015-03-05 2021-07-07 炎症性疾患におけるil-18結合タンパク質(il-18bp)および抗体

Country Status (17)

Country Link
US (4) US10882905B2 (cg-RX-API-DMAC7.html)
EP (1) EP3265807A1 (cg-RX-API-DMAC7.html)
JP (2) JP7274259B2 (cg-RX-API-DMAC7.html)
KR (1) KR102511343B1 (cg-RX-API-DMAC7.html)
CN (1) CN107660150B (cg-RX-API-DMAC7.html)
AU (1) AU2016227644B2 (cg-RX-API-DMAC7.html)
CA (1) CA2972689A1 (cg-RX-API-DMAC7.html)
CL (1) CL2017002237A1 (cg-RX-API-DMAC7.html)
CO (1) CO2017008940A2 (cg-RX-API-DMAC7.html)
IL (1) IL253292B2 (cg-RX-API-DMAC7.html)
MX (1) MX2017010919A (cg-RX-API-DMAC7.html)
MY (1) MY194040A (cg-RX-API-DMAC7.html)
PH (1) PH12017501402A1 (cg-RX-API-DMAC7.html)
RU (1) RU2755691C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201706879UA (cg-RX-API-DMAC7.html)
UA (1) UA128752C2 (cg-RX-API-DMAC7.html)
WO (1) WO2016139297A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015032932A1 (en) 2013-09-05 2015-03-12 Ab2 Bio Sa Il-18 binding protein (il-18bp) in inflammatory diseases
CN107660150B (zh) * 2015-03-05 2023-10-24 Ab2生物股份有限公司 Il-18结合蛋白(il-18bp)和抗体在炎性疾病中
US11787858B2 (en) 2016-12-22 2023-10-17 Icahn School Of Medicine At Mount Sinai Anti-LILRB3 antibodies and methods of use thereof
JP7795181B2 (ja) 2017-09-06 2026-01-07 イェール ユニバーシティー インターロイキン-18バリアントとその利用法
WO2019171258A1 (en) * 2018-03-05 2019-09-12 Janssen Pharmaceutica Nv Assays to detect neurodegeneration
US11912772B2 (en) * 2018-07-16 2024-02-27 University Of Hawaii Anti-galectin-9 antibody and methods of use thereof
CN108929382B (zh) * 2018-07-20 2019-10-15 深圳市第三人民医院 一种抗serinc5的抗体及其应用
US12269874B2 (en) 2018-12-03 2025-04-08 mAbProtein Co., Ltd. Antibody that recognizes neoepitope of activated interleukin-18 proteins and application thereof
EP3911680A4 (en) 2019-01-18 2022-09-07 University Health Network LILRB3 BINDING MOLECULES AND ASSOCIATED USES
US12594330B2 (en) 2019-06-04 2026-04-07 Regents Of The University Of Minnesota Anti-opioid compounds and methods of making and using same
CN112582058B (zh) * 2019-11-07 2022-04-01 广州医科大学 一种基于空气质量的慢阻肺发病预测方法及系统
BR112022020256A2 (pt) 2020-04-09 2023-01-03 Aprilbio Co Ltd “anticorpo monoclonal ou um fragmento de ligação ao antígeno do mesmo, ácido nucleico, vetor de expressão, célula, composição, uso da composição e uso do anticorpo monoclonal ou fragmento de ligação ao antígeno do mesmo
EP4146174A1 (en) 2020-05-06 2023-03-15 AB2 Bio SA Il-18 binding protein (il-18bp) in respiratory diseases
GB202007404D0 (en) * 2020-05-19 2020-07-01 Nasser Syed Muhammad Tahir Treatment for viral respiratory infections
TW202210511A (zh) * 2020-06-01 2022-03-16 美商阿法羅醫療股份有限公司 涉及il-18抗體之方法及治療
EP3943097A1 (en) 2020-07-24 2022-01-26 AB2 Bio SA Car-t cell therapy
CA3201637A1 (en) 2020-11-18 2022-05-27 Novartis Ag Bispecific antibodies for use in treatment of nlrc4-gof inflammasomapathy
WO2023067348A1 (en) 2021-10-21 2023-04-27 Biosirius Ltd Treatment for virally-induced pneumonia
AU2021479973A1 (en) * 2021-12-20 2024-07-04 Avalo Therapeutics, Inc. Methods and treatment for adult-onset still's disease and systemic-onset juvenile idiopathic arthritis involving antibodies to il-18
WO2023143535A1 (zh) * 2022-01-28 2023-08-03 和径医药科技(上海)有限公司 一种靶向il-18bp的抗体及其应用
EP4486367A1 (en) 2022-03-04 2025-01-08 AB2 Bio SA Il-18 binding protein (il-18bp) in the treatment of vexas
CA3259975A1 (en) * 2022-03-15 2023-09-21 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
JP2026503002A (ja) 2023-01-06 2026-01-27 アレクトル エルエルシー 抗il18結合タンパク質抗体及びその使用方法
EP4646433A1 (en) 2023-01-06 2025-11-12 Lassen Therapeutics, Inc. Anti-il-18bp antibodies
WO2026038145A1 (en) 2024-08-13 2026-02-19 Ab2 Bio Sa Il-18 binding protein (il-18bp) and methods of using same
CN119192356B (zh) * 2024-09-29 2025-05-27 华中农业大学 识别犬瘟热病毒h蛋白的单克隆抗体、检测试纸条及应用
CN119241693B (zh) * 2024-09-29 2025-05-27 华中农业大学 一种抗犬瘟热病毒的基因工程嵌合抗体及应用
CN120349409B (zh) * 2025-04-08 2026-03-17 生物岛实验室 Il-18bp纳米抗体及其制备方法与应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
GEP20002142B (en) 1991-01-18 2000-06-25 Amgen Inc Method for Treatment and Prevention of TNF Mediated Diseases
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
US5635599A (en) 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands
DE69526973T3 (de) 1994-10-21 2010-01-07 Innogenetics N.V. Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
IL121860A0 (en) 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
US7220717B2 (en) 1997-08-14 2007-05-22 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use
CA2340579A1 (en) * 1998-09-01 2000-03-09 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin 18-binding protein
AR022952A1 (es) * 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
SK12942002A3 (sk) 2000-02-10 2003-05-02 Abbott Laboratories Protilátky viažuce ľudský interleukín-18, spôsoby ich výroby a použitia
RS51737B (sr) 2000-02-21 2011-10-31 Laboratoires Serono Sa. Korišćenje inhibitora il-18
ES2365600T3 (es) * 2000-02-21 2011-10-07 Merck Serono Sa Uso de inhibidores de il-18.
CA2407895C (en) 2000-05-05 2012-12-18 Applied Research Systems Ars Holding N.V. Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
US20040198706A1 (en) 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
IL154751A0 (en) 2000-08-03 2003-10-31 Humanized antibodies, recombination vectors, transgenic vectors and methods for the preparation of humanized antibodies from transgenic animals
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders
IL157024A0 (en) 2001-01-29 2004-02-08 Applied Research Systems Il-18 inhibitors in heart disease
BR0210904A (pt) 2001-05-16 2005-08-16 Yeda Res & Dev Uso de inibidores de il-18 para o tratamento ou prevenção de sepse
US7655616B2 (en) 2001-05-25 2010-02-02 Ares Trading S.A. Use of IL-18 inhibitors for treating head injuries
US9592267B2 (en) * 2002-03-22 2017-03-14 Merck Serono Sa Use of IL-18BP for treatment of peripheral vascular diseases
BR0315155A (pt) * 2002-10-08 2005-08-16 Ares Trading Sa Uso de citocina capaz de ligar il-18bp e de inibir a atividade de uma segunda citocina
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
ATE399872T1 (de) 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
AU2004238524B2 (en) 2003-05-13 2011-06-23 Merck Serono Sa Active variants of the IL-18 binding protein and medical uses thereof
AU2011224023C1 (en) 2003-11-12 2013-08-29 Abbvie Inc. IL-18 binding proteins
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
IL159670A0 (en) * 2003-12-31 2004-06-01 Yeda Res & Dev Use of il-18 binding protein in inflammations
JP4160615B2 (ja) * 2004-03-11 2008-10-01 レドックス・バイオサイエンス株式会社 プロテアーゼ阻害剤
AU2005327198B2 (en) 2004-07-09 2011-03-31 University Of North Carolina At Chapel Hill Viral adjuvants
ATE526057T1 (de) 2004-08-20 2011-10-15 Glaxosmithkline Llc Wundheilung durch verabreichung von menschlichem il-18
CA2609060C (en) 2005-06-03 2014-07-15 Urs Weber Production of recombinant il-18 binding protein
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
WO2007030949A2 (en) 2005-09-15 2007-03-22 Val-Chum, S.E.C. Methods of diagnosing ovarian cancer and kits therefor
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
BR112013015508B1 (pt) * 2010-12-20 2022-04-05 Medimmune Limited Molécula de anticorpo para il-18 humana, domínio vh isolado e domínio vl isolado, composição, uso de uma molécula de anticorpo ou do domínio vh isolado e do domínio vl isolado, molécula de ácido nucleico isolada, célula hospedeira procariótica recombinante, método para produzir um anticorpo, e método in vitro para medir il-18 em uma amostra de um indivíduo
US9376489B2 (en) * 2012-09-07 2016-06-28 Novartis Ag IL-18 binding molecules
WO2015032932A1 (en) 2013-09-05 2015-03-12 Ab2 Bio Sa Il-18 binding protein (il-18bp) in inflammatory diseases
CN107660150B (zh) 2015-03-05 2023-10-24 Ab2生物股份有限公司 Il-18结合蛋白(il-18bp)和抗体在炎性疾病中

Similar Documents

Publication Publication Date Title
RU2017134857A (ru) Il-18-связывающие белок (il-18bp) и антитела при воспалительных заболеваниях
US20230250164A1 (en) IL-18 Binding Protein (IL-18BP) In Inflammatory Diseases
JP2016536332A5 (cg-RX-API-DMAC7.html)
JP2010534478A (ja) Il−18受容体抗原結合タンパク質
WO2015120185A1 (en) Novel assay to detect human periostin
BR112016030568B1 (pt) Método ex vivo para determinar se uma dose compreendendo uma proteína semelhante a anticorpo de região v dupla ou seu fragmento administrada a um indivíduo humano se liga especificamente a il-4 ou il-13 no indivíduo humano
CN119968391A (zh) 用抗白细胞介素-33抗体治疗哮喘
JP2025069136A (ja) 線維性疾患の治療のための抗エフリン-b2遮断抗体
JP2019525928A (ja) 抗体及び抗ウイルス剤の抗hsv相乗作用
TH1701005048A (th) โปรตีนเข้าจับ il-18 (il-18bp) และ แอนติบอดีในโรคที่มีการอักเสบ
TW202210511A (zh) 涉及il-18抗體之方法及治療
US20230091430A1 (en) TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION
TWI865759B (zh) 涉及過量游離light之方法及治療
EP4301408A1 (en) Treatment of atopic dermatitis employing anti-il-13ralpha1 antibody or binding fragment thereof in an allergic population
WO2025186779A1 (en) Oncolytic viruses expressing immunomodulators and use for treating advanced solid tumor
CN114641494A (zh) 抗-33治疗剂fpr治疗肾脏障碍
NZ733897B2 (en) Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases
HK1221726B (en) Il-18 binding protein (il-18bp) in inflammatory diseases